2nd Quarter - Report

NATIONAL COMMUNITY PHARMACISTS ASSOCIATION for NATIONAL COMMUNITY PHARMACISTS ASSOCIATION

Firm
Client
Income
—
Expenses
$310,000
Expense method
C: businesses, Internal Revenue Code section 162(e)

What was lobbied

8 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Small Business Tax Reform; H.R. 631, Death Tax Repeal Act of 2017; S. 205, Death Tax Repeal Act of 2017

LobbyistCovered position, as disclosed
RONNA HAUSER —
KARRY LA VIOLETTE —
SUSAN PILCH —
KEVIN SCHWEERS New Deputy Assistant Secretary, Public Affairs, Health and Human Services
MICHAEL TOMBERLIN —

Contacted: SENATE; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Government Accountability Office (GAO); Office of Personnel Management (OPM); Office of Management & Budget (OMB); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Health Resources & Services Administration (HRSA); Agriculture, Dept of (USDA); Medicare Payment Advisory Commission (MedPAC); Defense, Dept of (DOD); Office of Natl Drug Control Policy (NDCP); White House Office; Drug Enforcement Administration (DEA)

Bills named: S. 205 (115th), H.R. 631 (115th)

Defense DEF

Supporting implementation of Sec. 745 of National Defense Authorization Act for Fiscal Year 2017; H.R. 2810 - National Defense Authorization Act for Fiscal Year 2018- Generic drug pricing transparency and TRICARE Pharmacy Benefits Provisions; S. 1519 National Defense Authorization Act for Fiscal Year 2018- Generic drug pricing transparency and TRICARE Pharmacy Benefits Provisions

LobbyistCovered position, as disclosed
RONNA HAUSER —
KARRY LA VIOLETTE —
SUSAN PILCH —
KEVIN SCHWEERS New Deputy Assistant Secretary, Public Affairs, Health and Human Services
MICHAEL TOMBERLIN —

Contacted: Medicare Payment Advisory Commission (MedPAC); White House Office; Food & Drug Administration (FDA); Agriculture, Dept of (USDA); Defense, Dept of (DOD); Centers For Medicare and Medicaid Services (CMS); Office of Natl Drug Control Policy (NDCP); Health Resources & Services Administration (HRSA); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB); SENATE; Drug Enforcement Administration (DEA); Government Accountability Office (GAO); Office of Personnel Management (OPM)

Bills named: S. 1519 (115th), H.R. 2810 (115th)

Alcohol and Drug Abuse ALC

Implementation of Public Law 114-198 pharmacy provisions; Implementation of Public Law 114-255 pharmacy provisions; S. 778, the Prescription Drug Monitoring Act of 2017

LobbyistCovered position, as disclosed
RONNA HAUSER —
KARRY LA VIOLETTE —
SUSAN PILCH —
KEVIN SCHWEERS New Deputy Assistant Secretary, Public Affairs, Health and Human Services
MICHAEL TOMBERLIN —

Contacted: Office of Management & Budget (OMB); Office of Personnel Management (OPM); Centers For Medicare and Medicaid Services (CMS); Medicare Payment Advisory Commission (MedPAC); Health & Human Services, Dept of (HHS); Agriculture, Dept of (USDA); Office of Natl Drug Control Policy (NDCP); Food & Drug Administration (FDA); Drug Enforcement Administration (DEA); Government Accountability Office (GAO); Health Resources & Services Administration (HRSA); White House Office; Defense, Dept of (DOD); SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 778 (115th)

Animals ANI

Issues related to compounded pharmaceuticals for animals;

LobbyistCovered position, as disclosed
RONNA HAUSER —
KARRY LA VIOLETTE —
SUSAN PILCH —
KEVIN SCHWEERS New Deputy Assistant Secretary, Public Affairs, Health and Human Services
MICHAEL TOMBERLIN —

Contacted: Government Accountability Office (GAO); Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); Defense, Dept of (DOD); Medicare Payment Advisory Commission (MedPAC); Drug Enforcement Administration (DEA); HOUSE OF REPRESENTATIVES; Office of Natl Drug Control Policy (NDCP); White House Office; Health Resources & Services Administration (HRSA); Office of Personnel Management (OPM); Office of Management & Budget (OMB); SENATE; Food & Drug Administration (FDA); Agriculture, Dept of (USDA)

Health Issues HCR

S. 222, The Obama Care Replacement Act; S. 469, Affordable and Safe Prescription Drug Importation Act; H.R. 1245, Affordable and Safe Prescription Drug Importation Act; H.R. 1776, Improving Access to Affordable Prescription Drugs Act; S. 771, Improving Access to Affordable Prescription Drugs Act; H.R. 242, Medicare Prescription Drug Price Negotiation Act of 2017; S. 41, Medicare Prescription Drug Price Negotiation Act of 2017; Drug Pricing Transparency

LobbyistCovered position, as disclosed
RONNA HAUSER —
KARRY LA VIOLETTE —
SUSAN PILCH —
KEVIN SCHWEERS New Deputy Assistant Secretary, Public Affairs, Health and Human Services
MICHAEL TOMBERLIN —

Contacted: SENATE; Agriculture, Dept of (USDA); Office of Personnel Management (OPM); HOUSE OF REPRESENTATIVES; Office of Natl Drug Control Policy (NDCP); Office of Management & Budget (OMB); Medicare Payment Advisory Commission (MedPAC); Defense, Dept of (DOD); Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); Health Resources & Services Administration (HRSA); Drug Enforcement Administration (DEA); Government Accountability Office (GAO); White House Office; Food & Drug Administration (FDA)

Bills named: H.R. 1776 (115th), S. 222 (115th), S. 771 (115th), S. 469 (115th), S. 41 (115th), H.R. 242 (115th), H.R. 1245 (115th)

Medicare/Medicaid MMM

H.R. 1316, Prescription Drug Price Transparency Act; H.R. 1038, Improving Transparency and Accuracy in Medicare Part D Spending Act; S. 413, Improving Transparency and Accuracy in Medicare Part D Spending Act; H.R. 592, Pharmacy and Medically Underserved Areas Enhancement Act; S. 109, Pharmacy and Medically Underserved Areas Enhancement Act; H.R.1939 - To amend title XVIII of the Social Security Act to ensure equal access of Medicare beneficiaries to community pharmacies in underserved areas as network pharmacies under Medicare prescription drug coverage, and for other purposes; S.637 Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act of 2017;

LobbyistCovered position, as disclosed
RONNA HAUSER —
KARRY LA VIOLETTE —
SUSAN PILCH —
KEVIN SCHWEERS New Deputy Assistant Secretary, Public Affairs, Health and Human Services
MICHAEL TOMBERLIN —

Contacted: Agriculture, Dept of (USDA); Health & Human Services, Dept of (HHS); Defense, Dept of (DOD); Food & Drug Administration (FDA); Health Resources & Services Administration (HRSA); Office of Personnel Management (OPM); Medicare Payment Advisory Commission (MedPAC); Office of Natl Drug Control Policy (NDCP); Office of Management & Budget (OMB); White House Office; HOUSE OF REPRESENTATIVES; Drug Enforcement Administration (DEA); Government Accountability Office (GAO); SENATE; Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 1316 (115th), H.R. 1939 (115th), S. 637 (115th), S. 109 (115th), H.R. 592 (115th), S. 413 (115th), H.R. 1038 (115th)

Budget/Appropriations BUD

Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act; Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, specifically FDA funding for implementation of the Drug Quality and Security Act.; H.R. 1628, American Health Care Act of 2017; Better Care Reconciliation Act; H.R. 2430 the FDA Reauthorization Act (FDARA) of 2017; S.934 FDA Reauthorization Act of 2017;

LobbyistCovered position, as disclosed
RONNA HAUSER —
KARRY LA VIOLETTE —
SUSAN PILCH —
KEVIN SCHWEERS New Deputy Assistant Secretary, Public Affairs, Health and Human Services
MICHAEL TOMBERLIN —

Contacted: Agriculture, Dept of (USDA); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; White House Office; Office of Management & Budget (OMB); Medicare Payment Advisory Commission (MedPAC); SENATE; Defense, Dept of (DOD); Food & Drug Administration (FDA); Office of Personnel Management (OPM); Health Resources & Services Administration (HRSA); Health & Human Services, Dept of (HHS); Drug Enforcement Administration (DEA); Government Accountability Office (GAO); Office of Natl Drug Control Policy (NDCP)

Bills named: H.R. 2430 (115th), H.R. 1628 (115th), S. 934 (115th)

Pharmacy PHA

Congressional Oversight of 340 B Program; Issues related to FDA implementation of The Drug Quality and Security Act related to the regulations of pharmacy compounding; Biosimilar naming; H.R. 421 Allowing Greater Access to Safe and Effective Contraception Act; H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017

LobbyistCovered position, as disclosed
RONNA HAUSER —
KARRY LA VIOLETTE —
SUSAN PILCH —
KEVIN SCHWEERS New Deputy Assistant Secretary, Public Affairs, Health and Human Services
MICHAEL TOMBERLIN —

Contacted: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Office of Personnel Management (OPM); Medicare Payment Advisory Commission (MedPAC); SENATE; Health & Human Services, Dept of (HHS); Office of Natl Drug Control Policy (NDCP); Office of Management & Budget (OMB); White House Office; Drug Enforcement Administration (DEA); Health Resources & Services Administration (HRSA); Agriculture, Dept of (USDA); Defense, Dept of (DOD); Government Accountability Office (GAO)

Bills named: H.R. 2871 (115th), H.R. 421 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.